Home  >  News
  GeNeuro regains worldwide rights ex US & Japan to GNbAC1 in MS from Servier,   September 19, 2018
  Samumed, United Therapeutics ink North American licensing pact for idiopathic pulmonary fibrosis drug, SM04646,   September 18, 2018
  Mylan introduces generic Brevibloc in US markets,   September 15, 2018
  ViiV Healthcare seeks European marketing nod for single-tablet, two-drug regimen of dolutegravir & lamivudine to treat HIV,   September 15, 2018
  Dr Reddy's Labs launches generic Bloxiverz injection in US market,   September 14, 2018
  Glenmark receives marketing approval in Germany for generic Seretide Accuhaler,   September 10, 2018
  Croma-Pharma, Botulax partner to introduce HA filler and PDO thread products in US market,   September 08, 2018
  NICE recommends marketing approval for Kyowa Kirin's Crysvita to treat rare metabolic bone disorder,   September 07, 2018
  Zydus receives US FDA marketing approval for generic Zovirax,   September 05, 2018
  Alnylam's Onpattro receives European marketing authorization,   September 04, 2018
  Sanofi receives European marketing approval for Cablivi to treat adults with aTTP,   September 04, 2018
  GSK's paediatric asthma medicine Nucala receives European marketing approval,   August 31, 2018
  Zydus receives US FDA marketing approval for gemfibrozil & aripiprazole tablets,   August 30, 2018
  GrĂ¼nenthal's Duzallo gets European marketing authorization to treat hyperuricaemia in adult gout patients,   August 30, 2018
  Chugai Pharma, Nippon Shinyaku launch humanized anti-CD20 monoclonal antibody Gazyva,   August 30, 2018
  Glenmark to market generic tiotropium bromide dry powder inhaler in Western Europe,   August 29, 2018
  Ultragenyx Pharma receives European marketing approval for Mepsevii to treat Mucopolysaccharidosis VII,   August 28, 2018
  Jazz Pharma receives European marketing approval for Vyxeos to treat certain type of high risk AML,   August 28, 2018
  Bayer seeks European marketing nod for larotrectinib to treat TRK fusion cancer,   August 28, 2018
  Sobi acquires global rights for emapalumab from Novimmune,   August 25, 2018

Copyright © 2016 Saffron Media Pvt. Ltd |